AstraZeneca makes deal with White House to lower drug prices

Sydney Lupkin

October 10, 2025 / 4:21 pm

AstraZeneca became the second drugmaker to enter a deal with the Trump administration to offer lower prices to Medicaid and to offer some of its drugs at a discount through TrumpRx , a government website to facilitate sales directly to consumers.

"In other words the lowest price anywhere in the world, that's what we get," President Trump said during an Oval Office press conference Friday. The centerpiece of the deal is most-favored-nation pricing for drugs sold to Medicaid. That would link Medicaid prices to the lower ones paid in other developed countries.

As part of the deal, AstraZeneca will also offer discounts of up to 80% off list prices on direct sales to consumers, acc

See Full Page